Microbiological Assay for Pharmaceutical Analysis: A Rational Approach [1 ed.] 0849318246, 9780849318245, 020350397X, 9780203503973, 9780203614419

A user-friendly guide for the evaluation of microbiological assays, Microbiological Assay for Pharmaceutical Analysis: A

296 97 2MB

English Pages 260 Year 2003

Report DMCA / Copyright

DOWNLOAD PDF FILE

Table of contents :
Book Cover......Page 1
Title......Page 3
Copyright......Page 4
Preface......Page 5
Author Biography......Page 7
Acknowledgments......Page 9
Table of Contents......Page 11
1 Microbiological Assay in Perspective......Page 17
2 The Agar Diffusion Assay—Its Quantitative Basis......Page 25
3 The Theory and Practice of Tube Assays for Growth-Promoting Substances......Page 39
4 The Theory and Practice of Tube Assays for Growth-Inhibiting Substances......Page 53
5 What Do We Want of an Assay? How Do We Attain Our Goal?......Page 75
6 General Practical Aspects of Microbiological Assays......Page 81
7 Standard Reference Materials......Page 95
8 Preliminary Evaluation of Data......Page 105
9 Parallel-Line Assays—Some Designs and Their Evaluation......Page 113
10 Slope Ratio Assays—Some Designs and Their Evaluation......Page 185
11 Choice of Experimental Design......Page 199
12 Concluding Thoughts......Page 223
Appendices......Page 233
Index......Page 253
Recommend Papers

Microbiological Assay for Pharmaceutical Analysis: A Rational Approach [1 ed.]
 0849318246, 9780849318245, 020350397X, 9780203503973, 9780203614419

  • 0 0 0
  • Like this paper and download? You can publish your own PDF file online for free in a few minutes! Sign Up
File loading please wait...
Citation preview

Microbiological Assay for Pharmaceutical Analysis A Rational Approach

Microbiological Assay for Pharmaceutical Analysis A Rational Approach

William Hewitt Interpharm /CRC Boca Raton London New York Washington, D.C.

This edition published in the Taylor & Francis e-Library, 2005. “To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk.”

/LEUDU\RI&RQJUHVV&DWDORJLQJLQ3XEOLFDWLRQ'DWD +HZLWW:LOOLDP² 0LFURELRORJLFDODVVD\IRUSKDUPDFHXWLFDODQDO\VLVDUDWLRQDODSSURDFK:LOOLDP+HZLWW SFP ,QFOXGHVELEOLRJUDSKLFDOUHIHUHQFHVDQGLQGH[ ,6%1 0LFURELRORJLFDODVVD\0LFURELRORJLFDODVVD\0DWKHPDWLFV,7LWOH >'1/0%LRORJLFDODVVD\PHWKRGV'DWD,QWHUSUHWDWLRQ6WDWLVWLFDO'RVDJH )RUPVVWDQGDUGV'UXJ6WDELOLW\0LFURELRORJLFDO7HFKQLTXHV3KDUPDFHXWLFDO 3UHSDUDWLRQVDQDO\VLV49+PD@ 450+ v³GF  7KLVERRNFRQWDLQVLQIRUPDWLRQREWDLQHGIURPDXWKHQWLFDQGKLJKO\UHJDUGHGVRXUFHV5HSULQWHGPDWHULDO LVTXRWHGZLWKSHUPLVVLRQDQGVRXUFHVDUHLQGLFDWHG$ZLGHYDULHW\RIUHIHUHQFHVDUHOLVWHG5HDVRQDEOH HIIRUWVKDYHEHHQPDGHWRSXEOLVKUHOLDEOHGDWDDQGLQIRUPDWLRQEXWWKHDXWKRUDQGWKHSXEOLVKHUFDQQRW DVVXPHUHVSRQVLELOLW\IRUWKHYDOLGLW\RIDOOPDWHULDOVRUIRUWKHFRQVHTXHQFHVRIWKHLUXVH 1HLWKHUWKLVERRNQRUDQ\SDUWPD\EHUHSURGXFHGRUWUDQVPLWWHGLQDQ\IRUPRUE\DQ\PHDQVHOHFWURQLF RUPHFKDQLFDOLQFOXGLQJSKRWRFRS\LQJPLFURÀOPLQJDQGUHFRUGLQJRUE\DQ\LQIRUPDWLRQVWRUDJHRU UHWULHYDOV\VWHPZLWKRXWSULRUSHUPLVVLRQLQZULWLQJIURPWKHSXEOLVKHU 7KHFRQVHQWRI&5&3UHVV//&GRHVQRWH[WHQGWRFRS\LQJIRUJHQHUDOGLVWULEXWLRQIRUSURPRWLRQIRU FUHDWLQJQHZZRUNVRUIRUUHVDOH6SHFLÀFSHUPLVVLRQPXVWEHREWDLQHGLQZULWLQJIURP&5&3UHVV//& IRUVXFKFRS\LQJ 'LUHFWDOOLQTXLULHVWR&5&3UHVV//&1:&RUSRUDWH%OYG%RFD5DWRQ)ORULGD 7UDGHPDUN1RWLFH 3URGXFWRUFRUSRUDWHQDPHVPD\EHWUDGHPDUNVRUUHJLVWHUHGWUDGHPDUNVDQGDUH XVHGRQO\IRULGHQWLÀFDWLRQDQGH[SODQDWLRQZLWKRXWLQWHQWWRLQIULQJH

9LVLWWKH&5&3UHVV:HEVLWHDWZZZFUFSUHVVFRP ‹E\&5&3UHVV//& ,QWHUSKDUPLVDQLPSULQWRI&5&3UHVV//& 1RFODLPWRRULJLQDO86*RYHUQPHQWZRUNV ,QWHUQDWLRQDO6WDQGDUG%RRN1XPEHU /LEUDU\RI&RQJUHVV&DUG1XPEHU ISBN 0-203-50397-X Master e-book ISBN

ISBN 0-203-58859-2 (Adobe eReader Format)

Preface 2QHPXVWKDYHUHDVRQVIRUZULWLQJDERRN³WKHSUHIDFHSURYLGHVDQRSSRUWXQLW\ WRH[SODLQWKRVHUHDVRQV 0\EDFNJURXQGLVWKDWRIDQDQDO\WLFDOFKHPLVW%\FKDQFH,EHFDPHLQYROYHG LQPLFURELRORJLFDODVVD\VRPHGHFDGHVDJRDQGDOVREHFDPHLQWULJXHGE\WKHVHHP LQJO\XQXVXDOFDOFXODWLRQVWKDWZHUHXVHGWRDUULYHDWHVWLPDWHGSRWHQF\DQGFRQÀ GHQFH OLPLWV IRU WKH HVWLPDWH , ZDV IRUWXQDWH LQ KDYLQJ H[FHOOHQW WXWRUV ³ LQ SDUWLFXODU 3HWHU 7RRWLOO ZKR KDG EHHQ SURPLQHQW LQ SURPRWLQJ WKH XVH RI JRRG H[SHULPHQWDOGHVLJQVLQWKHVDQGV 6RPH\HDUVODWHU,HPEDUNHGRQDQRYHUVHDVFDUHHUDVDQDGYLVRURQDQDO\WLFDO FKHPLVWU\LQ(XURSH,QHYLWDEO\P\DWWHQWLRQZDVGUDZQWRWKHODFNRIXQGHUVWDQGLQJ RI WKH EDVLF PDWKHPDWLFDO SULQFLSOHV RI PLFURELRORJLFDO DVVD\ WKH DJDU GLIIXVLRQ DVVD\IRUDQWLELRWLFV ,VHWRXWWREULQJHQOLJKWHQPHQWLQWKLVÀHOG7KLVZDVÀUVWE\ VRPHSULQWHGQRWHVIRUORFDOXVH/DWHUUHFRJQL]LQJWKHZLGHUSRWHQWLDODSSOLFDWLRQ RI WKHVH QRWHV , ZDV DEOH WR H[SDQG RQ WKHP YHU\ VXEVWDQWLDOO\ DQG SXEOLVKHG 0LFURELRORJLFDO$VVD\$Q,QWURGXFWLRQWR4XDQWLWDWLYH3ULQFLSOHVDQG(YDOXDWLRQ LQ  ERRN 1R   ,W LV IDVFLQDWLQJ WR FRQWHPSODWH WKDW WKLV ERRN ZLWK LWV LQQXPHUDEOHFDOFXODWLRQVZDVDVVHPEOHGZLWKWKHDLGRIDPHFKDQLFDOW\SHZULWHUD ORWRIFRUUHFWLRQÁXLGDQGDSRFNHWFDOFXODWRU 6RPH \HDUV ODWHU VWLOO ZRUNLQJ DV DQ RYHUVHDV DGYLVRU DQG VWLOO YHU\ PXFK DQ DQDO\WLFDOFKHPLVW ,EHFDPHHYHQPRUHLPSUHVVHGE\WKHODFNRIDSSUHFLDWLRQRIWKH EDVLF SUDFWLFDO DZDUHQHVV QHHGHG WR DFKLHYH VXFFHVV LQ WKH ÀHOG RI PLFURELRORJLFDO DVVD\ 0DQDJHUV ZHUH VRPHWLPHV PLFURELRORJLVWV ³ PXFK PRUH FRPSHWHQW WKDQ P\VHOI LQ PLFURELRORJ\ EXW QRW VXIÀFLHQWO\ DZDUH WKDW WKH PLFURELRORJLFDO DVVD\ RI DQWLELRWLFV QHHGHG WR EH WUHDWHG DV D EUDQFK RI DQDO\WLFDO FKHPLVWU\ , UHFDOO RQH ODERUDWRU\LQZKLFK,IRXQGQRIDXOWZLWKWKHPLFURELRORJLFDODVSHFWRIWKHZRUNEXW LQZKLFKWKHRSWLFDOFRPSRQHQWVRIWKH]RQHPHDVXULQJGHYLFHZHUHFRDWHGZLWKWKH ÀQHVDQGVRIDORFDOGHVHUW7KLVDQGRWKHUVLPLODUREVHUYDWLRQVSURPSWHGPHWRWKLQN DERXWZULWLQJDERRNFRQFHUQHGZLWKWKHSUDFWLFDODVSHFWVRIPLFURELRORJLFDODVVD\ )RU WKLV , QHHGHG D FRDXWKRU , ZDV YHU\ IRUWXQDWH LQ PHHWLQJ 6WHSKHQ9LQFHQW RI *OD[R/DERUDWRULHV8.6WHSKHQKDGYDVWH[SHULHQFHRIUXQQLQJDPLFURELRORJLFDO DVVD\ ODERUDWRU\ KH DJUHHG WR FROODERUDWH ZLWK PH 7KH RXWFRPH ZDV 7KHRU\ DQG $SSOLFDWLRQRI0LFURELRORJLFDO$VVD\+HZLWWDQG9LQFHQW ERRN1R  %RRN1RDSSHDUVWRKDYHVHUYHGLWVSXUSRVH,QSDUWLFXODULWSURYLGHGJXLGDQFH RQWKHPDWKHPDWLFDODVSHFWVRIPLFURELRORJLFDODVVD\VLQDIRUPPRUHUHDGDEOHWKDQ WKHSKDUPDFRSRHLDV:KLOHWKHIXQGDPHQWDOPDWKHPDWLFDOWUXWKVH[SRXQGHGLQWKDW ERRNDUHDVYDOLGLQDVWKH\ZHUHLQWKHERRNLVPXFKRXWGDWHG,WZDV ZULWWHQ EHIRUH WKH DGYHQW RI SHUVRQDO FRPSXWHUV %HFDXVH RI WKH LQWHQVH ODERU LQYROYHGLQDPDQXDOFDOFXODWLRQRIDVWDWLVWLFDOHYDOXDWLRQ W\SLFDOO\RQHKRXU·VZRUN IRUDQH[SHULHQFHGSHUVRQ VXFKFDOFXODWLRQVZHUHUHJDUGHGDVVRPHWKLQJQRWWREH

DSSOLHGWRHDFKDVVD\EXWDVDGHPRQVWUDWLRQRIWKHSUHFLVLRQWKDWFRXOGEHH[SHFWHG RIDQDVVD\ 1RZDGD\VRQFHWKHSURJUDPKDVEHHQVHWXSRQWKHFRPSXWHUWKHFDOFXODWLRQ LVHIIRUWOHVV7KLVPLJKWVHHPWRLPSO\WKDWWKHDQDO\VWQHHGQRWFRQFHUQKLPVHOIRU KHUVHOIZLWKWKHFDOFXODWLRQEHLQJVDWLVÀHGWKDWLWKDVEHHQVHWXSE\DFRPSHWHQW VWDWLVWLFLDQDQGYDOLGDWHG+RZHYHU(XURSHDQSKDUPDFRSRHLDJXLGDQFHLVRWKHUZLVH 5HIHUULQJWRFRPSXWHUSURJUDPVWKHSKDUPDFRSRHLDGLUHFWVWKDW WKHÀQDOGHFLVLRQ WRDFFHSWUHMHFWRUPRGLI\WKHREVHUYHGGDWDPXVWEHWDNHQE\WKHDQDO\VWLQWKH OLJKWRIWKHGHWDLOHGUHVXOWVJLYHQE\WKHFRPSXWHU,QUHDFKLQJDGHFLVLRQWKHDQDO\VW VKRXOGEHDULQPLQGWKDW´VWDWLVWLFDOVLJQLÀFDQFHµLVQRWV\QRQ\PRXVZLWK´SUDFWLFDO LPSRUWDQFHµ³DIDFWWKDWLVZHOOLOOXVWUDWHGLQWKLVERRN :KLOHWKHDQDO\VWZLOOSUREDEO\DFFHSWWKHSULQFLSOHVRIWKHVWDWLVWLFDOHYDOXDWLRQ ZLWKRXWKDYLQJDWKRURXJKXQGHUVWDQGLQJRIVWDWLVWLFDOWKHRU\WKHUHLVFOHDUO\DQHHG IRUWKHDQDO\VWWRXQGHUVWDQGKRZWKHFDOFXODWLRQVZRUN,QWKHDQDO\VLVRIYDULDQFH LW LV QHFHVVDU\ WR EH DEOH WR LGHQWLI\ ZK\ YDULDWLRQ DWWULEXWDEOH WR DQ\ VRXUFH LV VWDWLVWLFDOO\VLJQLÀFDQW³WKHQWRDVVHVVZKHWKHUWKDWVLJQLÀFDQFHLVUHDOO\JRLQJWR MHRSDUGL]HWKHUHOLDELOLW\RIWKHDVVD\$PDMRUREMHFWLYHRIWKLVERRNLVWRSURYLGH DQLQVLJKWLQWRKRZWKHFDOFXODWLRQVZRUNDQGWRKHOSDQDO\VWVPDNHMXGJPHQWVRQ YDOLGLW\ 2QWKHSUDFWLFDOVLGHWKHREMHFWLYHVRIWKHERRNDUHPRUHOLPLWHG7KHUHH[LVWV H[FHOOHQWGHWDLOHGJXLGDQFHRQSUDFWLFDODVSHFWVRIWKHVXEMHFWLQ6WHSKHQ9LQFHQW·V FRQWULEXWLRQWRERRN7KLVLVQRWRXWGDWHG7KHJXLGDQFHJLYHQKHUHGUDZVDWWHQWLRQ WRWKHPLFURELRORJLFDODVSHFWVZKLFKPD\QRWEHVRREYLRXVWRWKHFKHPLFDODQDO\VW DQG WR DQDO\WLFDO DVSHFWV WKDW PD\ QRW EH VR REYLRXV WR WKH PLFURELRORJLVW $Q LPSRUWDQWIHDWXUHFRQFHUQVWKHQHHGIRUVWHULOHHTXLSPHQWDQGDVHSWLFWHFKQLTXHV )HZ ERRNV KDYH EHHQ ZULWWHQ SUHVHQWLQJ DQ RYHUDOO YLHZ RI PLFURELRORJLFDO DVVD\ 7KH YHU\ FRPSUHKHQVLYH $QDO\WLFDO 0LFURELRORJ\ HGLWHG E\ )UHGHULFN .DYDQDJK³YROXPHLQDQGYROXPHLQ³UHPDLQVRIJUHDWYDOXHWR WKRVHSUDFWLFLQJPLFURELRORJLFDODVVD\WRGD\,WLVKRSHGWKDW0LFURELRORJLFDO$VVD\ IRU3KDUPDFHXWLFDO$QDO\VLV$5DWLRQDO$SSURDFKZLOOVHUYHLWVLQWHQGHGSXUSRVH LQSURYLGLQJDQXSGDWHRQHDUOLHUSXEOLFDWLRQV

Author Biography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

Acknowledgments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³&KDSWHULQFOXGHVDGDSWDWLRQVIURP WKH ZRUN RI *DUUHWW DQG 0LOOHU  7KHVH DGDSWDWLRQV DUH PDGH ZLWK WKH NLQG SHUPLVVLRQRI:LOH\/LVV,QFDVXEVLGLDU\RI-RKQ:LOH\ 6RQV,QF 7KH8QLWHG6WDWHV3KDUPDFRSRHLDO&RQYHQWLRQ³&KDSWHUPDNHVUHIHUHQFHWR 863 WHVWV IRU RXWOLHUV DQG &KDSWHU  LQWURGXFHV WKH FKLVTXDUHG WHVW7KH FRUUH VSRQGLQJWDEOHVRIDQQH[HVDQGDUHUHSULQWHGZLWKSHUPLVVLRQ7KH8QLWHG6WDWHV 3KDUPDFRSRHLDO&RQYHQWLRQ,QF‹$OOULJKWVUHVHUYHG 7KH (XURSHDQ 3KDUPDFRSRHLD &RPPLVVLRQ ³ ([WUDFWV IURP WKH FKDSWHUV RQ VWDWLVWLFDODQDO\VLVRIIRXUHGLWLRQVRIWKH(3DUHTXRWHGRUUHSURGXFHGZLWKWKHNLQG SHUPLVVLRQRIWKH(XURSHDQ3KDUPDFRSRHLD&RPPLVVLRQ,Q&KDSWHUWKHUHLVRQH TXRWDWLRQLQ&KDSWHUWKURXJK&KDSWHUWKHUHDUHIRXUTXRWDWLRQV(GLWLRQDQG SDJHUHIHUHQFHVDUHJLYHQLQWKHUHIHUHQFHOLVWDWWKHHQGRIHDFKFKDSWHU 7KH:RUOG +HDOWK 2UJDQL]DWLRQ ³ ,Q &KDSWHU  UHIHUHQFH LV PDGH WR WKH:+2 SXEOLFDWLRQ´$FFHOHUDWHG6WDELOLW\6WXGLHVRI:LGHO\8VHG3KDUPDFHXWLFDO6XEVWDQFHV

XQGHU6LPXODWHG7URSLFDO&RQGLWLRQVµ  7DEOHDQG7DEOHDUHEDVHGRQ LQIRUPDWLRQ DEVWUDFWHG IURP WKLV SXEOLFDWLRQ ZLWK WKH NLQG SHUPLVVLRQ RI WKH:RUOG +HDOWK2UJDQL]DWLRQ,Q&KDSWHUUHIHUHQFHLVPDGHWRDSXEOLFDWLRQLQWKH-RXUQDO RI%LRORJLFDO6WDQGDUGL]DWLRQ$QQH[LVWDNHQIURPWKDWSXEOLFDWLRQDQGLVUHSURGXFHG YHUEDWLPZLWKWKHNLQGSHUPLVVLRQRIWKH:RUOG+HDOWK2UJDQL]DWLRQ 7KH6RFLHW\IRU*HQHUDO0LFURELRORJ\IRUJUDQWLQJSHUPLVVLRQWRUHSURGXFHÀ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ÀQGLQJV 6WHSKHQ9LQFHQW IRUPHUO\ RI *OD[R /DERUDWRULHV 8. IRU UHYLHZLQJ &KDSWHU  DQGPDNLQJYDOXDEOHVXJJHVWLRQV

Table of Contents &KDSWHU

0LFURELRORJLFDO$VVD\LQ3HUVSHFWLYH 

%LRORJLFDO$VVD\VLQ*HQHUDO  7KH'LIIHUHQW6RUWVRI0LFURELRORJLFDO$VVD\ 7KH$JDU'LIIXVLRQ$VVD\  7KH7XEHRU)ODVN$VVD\IRU*URZWK3URPRWLQJ6XEVWDQFHV 7KH7XEH$VVD\IRU*URZWK,QKLELWLQJ6XEVWDQFHV  7KH%DVLVRI&DOFXODWLRQRI3RWHQF\(VWLPDWHV 3DUDOOHO/LQH$VVD\V 6ORSH5DWLR$VVD\V :KLFK0DWKHPDWLFDO0RGHO"  5HIHUHQFHV &KDSWHU

7KH$JDU'LIIXVLRQ$VVD\³,WV4XDQWLWDWLYH%DVLV 

+LVWRULFDO,QWURGXFWLRQ 7KH7KHRU\RI=RQH)RUPDWLRQ :KDW+DSSHQVLQ3UDFWLFH 3ULQFLSOHRI&DOFXODWLRQRI3RWHQF\(VWLPDWH 5HIHUHQFHV &KDSWHU

7KH7KHRU\DQG3UDFWLFHRI7XEH$VVD\VIRU*URZWK3URPRWLQJ 6XEVWDQFHV 

,QWURGXFWLRQ 7KH0RGHRI$FWLRQRI*URZWK3URPRWLQJ6XEVWDQFHV  *URZWK/LPLWHGE\$PLQR$FLGV  *URZWK/LPLWHGE\9LWDPLQV  3URGXFWLRQRI$FLGE\/DFWREDFLOOL &ULWLFDO)DFWRUVLQWKH$VVD\RI*URZWK3URPRWLQJ6XEVWDQFHV  2WKHU6RXUFHVRI(UURU  5HIHUHQFHV &KDSWHU

7KH7KHRU\DQG3UDFWLFHRI7XEH$VVD\VIRU*URZWK,QKLELWLQJ 6XEVWDQFHV 

+LVWRULFDO,QWURGXFWLRQ 0HDVXUHPHQWRI5HVSRQVH

7KH)RUPRIWKH5HVSRQVH/LQH +LVWRULFDO'HYHORSPHQWRIWKH7XUELGLPHWULF0HWKRG  /LQHDUL]DWLRQRI6LJPRLG&XUYHV  7KH4XDQWLWDWLYH7KHRU\RI0LFURELDO*URZWKDQG,QKLELWLRQ $3UDFWLFDOO\'HWHUPLQHG/RJ'RVH5HVSRQVH&XUYH  )DFWRUV$IIHFWLQJ)LQDO&HOO&RXQW  7KH,QÁXHQFHRI7HPSHUDWXUH 7KH,QÁXHQFHRI7LPH  6XPPDU\DQG&RQFOXVLRQV 5HIHUHQFHV &KDSWHU

:KDW'R:H:DQWRIDQ$VVD\"+RZ'R:H$WWDLQ2XU*RDO" 

,QWURGXFWLRQ 3KDUPDFRSRHLDO,QWHQWLRQ  &RQWURORI$QWLELRWLF%XON0DWHULDOV  &RQWUROLQ5RXWLQH0DQXIDFWXUH  5HVHDUFKDQG'HYHORSPHQW   ²  @ ==  

Parallel-Line Assays — Some Designs and Their Evaluation

119

7KHUH DUH WZR FRQWUDVWV RYHU WZR GRVH LQWHUYDOV HDFK KDYLQJ D UHSOLFDWLRQ RI VL[ KHQFHWKHGHQRPLQDWRU 6WHS  &DOFXODWH ) WKH PHDQ GLIIHUHQFH EHWZHHQ XQNQRZQ DQG VWDQGDUG UHVSRQVHV ) >  ²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tatistical Evaluation 7KHDQDO\VLVRIYDULDQFHFRPSULVHVWZRSDUWV  ,GHQWLÀFDWLRQRIYDULDQFHGXHWRWKHVL[GLIIHUHQWWUHDWPHQWV  ,GHQWLÀFDWLRQRIYDULDQFHGXHWRGLIIHUHQWEORFNV³URZVDQGFROXPQVRQ WKHSODWHLQWKLVSDUWLFXODUDVVD\GHVLJQ 9DULDQFH GXH WR WKH GLIIHUHQW LQGLYLGXDO WUHDWPHQWV LV FDOFXODWHG XVLQJ RUWKRJRQDO SRO\QRPLDOFRHIÀFLHQWVDVVKRZQLQ7DEOH

120

Microbiological Assay for Pharmaceutical Analysis

TABLE 9.6 Factorial Coefficients for a Three-Dose Level Symmetrical Assay Applied to the Data of Example 9.2 as a Part of the Analysis of Variance Row D E DE T DT 7UHDWPHQW 7RWDOVA

S1

S2

S3

U1

U2

U3

² ²   ²

²   ² 

²  ²  ²

 ² ²  

   ² ²

    













ei

Ti

    

²   ² 

Ti2/(6 = ei)     

9DOXHVIRUWKHUHPDLQLQJVRXUFHVRIYDULDWLRQDUHFDOFXODWHGWKXV 6WHS  )URP WKH UDZ GDWD DV DSSHDULQJ RQ WKH SODWH FDOFXODWH WKH WRWDO GHYLDWLRQVTXDUHVDV







   7     <    

   ²      

PHDQFRUUHFWLRQ 0&  



    



6WHS)URPWKHURZWRWDOVDVDSSHDULQJRQWKHSODWHFDOFXODWH







          < 0&

    ²      6WHS)URPWKHFROXPQWRWDOVDVDSSHDULQJRQWKHSODWHFDOFXODWH







       < 0&

    ²      6WHS)URPWKHWUHDWPHQWWRWDOVFDOFXODWH







          < 0&

    ²      

121

Parallel-Line Assays — Some Designs and Their Evaluation

$VXPPDU\RIWKHDQDO\VLVRIYDULDQFHLVSUHVHQWHGLQ7DEOH Discussion of Assay Validity Based on the Analysis of Variance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ÀGHQFHOLPLWVIRUWKHSRWHQF\ HVWLPDWHPD\EHFDOFXODWHG

TABLE 9.7 Summary of Analysis of Variance, Example 9.2, a Three-Dose Level Assay Using a Large Plate and a 6 = 6 Latin Square Design Source of Variance

d.f.

Sums of Squares

Mean Squares

         

3UHSDUDWLRQV 5HJUHVVLRQ 3DUDOOHOLVP 4XDGUDWLFFXUYDWXUH 2SSRVHGFXUYDWXUH

    

    

6XEWRWDO





7UHDWPHQWV 5RZV &ROXPQV (UURUE\GLIIHUHQFH

   

   

7RWDO





  

Variance Ratio

  

Limiting Value

At Arbitrary Probability Level, P

 !   

    

    

 

 

 

Calculated Probability

1RWH/LPLWLQJYDOXHVLQFROXPQUHIHUWRWKHFRUUHVSRQGLQJDUELWUDU\SUREDELOLW\OHYHORIFROXPQ

122

Microbiological Assay for Pharmaceutical Analysis

6WHS&DOFXODWHWKHWHUP6[[WKHVXPRIWKHVTXDUHVRIGHYLDWLRQVRILQGL YLGXDOORJGRVHVIURPWKHPHDQORJGRVH7KHGRVHUDWLRLVVRWKHORJ GRVH LQWHUYDO LV  7KHUH DUH  KLJK DQG  ORZ GRVHV PLG GRVHV FRQWULEXWHQRWKLQJWRWKLVFDOFXODWLRQVRWKHYDOXHLVREWDLQHGDV 6[[ =>   ² @  6WHS&DOFXODWHJWKHLQGH[RIVLJQLÀFDQFHRIWKHVORSHEDV J

V = W  E  = 6[[



VRWKDWLQWKLVDVVD\ J

 =       = 

ZKHUHVEDQG6[[KDYHWKHYDOXHVDOUHDG\FDOFXODWHGDQGWLV6WXGHQW·VWREWDLQHG IURPWDEOHVIRU3 DQGGHJUHHVRIIUHHGRPDV$EULHIIRUPRIWKLV WDEOHLVJLYHQLQ$SSHQGL[ $VJLVOHVVWKDQFDOFXODWHFRQÀGHQFHOLPLWVRIWKHSRWHQF\HVWLPDWHVE\WKHVR FDOOHGDSSUR[LPDWHPHWKRG 6WHS&DOFXODWH9 0v WKHYDULDQFHRIWKHORJDULWKPRIWKHSRWHQF\HVWLPDWH RIWKHXQNQRZQE\VXEVWLWXWLQJWKHNQRZQYDOXHVLQWKHHTXDWLRQ

90 

V E

•  0 — 



³ µ – 1 V 17 6[[ ˜

90 

  



•    — ³ 

µ  – ˜

      6WHS2EWDLQVP WKHVWDQGDUGHUURURIWKHORJDULWKPRIWKHSRWHQF\HVWLPDWH DV VP >9 0 @ ZKHUHYDOXHVDUH VP    



Parallel-Line Assays — Some Designs and Their Evaluation

123

6WHS/RJSHUFHQWFRQÀGHQFHOLPLWVDUHJLYHQE\ “W=VP



ZKHUHYDOXHVDUH “= DQG 7KHFRUUHVSRQGLQJSHUFHQWDJHOLPLWVDUHDQG 3   $OWHUQDWLYHO\H[SUHVVHGLQWHUPVRIWKHVWDQGDUGSRWHQF\WKHHVWLPDWHGSRWHQF\LV ZLWKOLPLWVWR 3  

A TWO-DOSE LEVEL ASSAY FOR FOUR PREPARATIONS (THREE UNKNOWNS) USING A LARGE PLATE AND AN 8 = 8 LATIN SQUARE DESIGN 7KLVDVVD\XVLQJDQ=/DWLQVTXDUHGHVLJQSURYLGHVIRUWKHVLPXOWDQHRXVDVVD\ RI WKUHH XQNQRZQV DW WZR GRVH OHYHOV (DFK WUHDWPHQW KDV D UHSOLFDWLRQ RI HLJKW FRUUHVSRQGLQJWRREVHUYDWLRQVSHUSUHSDUDWLRQ7KLVGHVLJQPD\EHXVHIXOLQURXWLQH TXDOLW\ FRQWURO LQ WKH SKDUPDFHXWLFDO LQGXVWU\ ZKHQ OHYHOV RI ´DVVLJQHG SRWHQF\µ EHIRUHDVVD\ PD\EHJLYHQZLWKUHDVRQDEOHFRQÀGHQFH7KHGRVHUDWLRHPSOR\HGLV IUHTXHQWO\  RU  ,Q WKLV FDVH WKH UDWLR FKRVHQ ZDV  QR GRXEW EHFDXVH WKH JHQHUDOO\SRRUVORSHRIQHRP\FLQDVVD\VSHUPLWVDZLGHUUDQJHWREHXVHG (;$03/($1$66$  ²  @  6WHS)URPWKHKLJKDQGORZGRVHWRWDOVIRULQGLYLGXDOSUHSDUDWLRQVFDO FXODWHSDUDOOHOLVPVTXDUHVDV

!  <      <    # 



² UHJUHVVLRQVTXDUHV

 ² 



6WHS&DOFXODWHZHLJKLQJVZLWKLQSUHSDUDWLRQVDV

!6$

+





6$/ <  6%+ 6%/

# !8$



+

!  <    #

!  <    #   









8$/ < 8%+ 8%/

#



138

Microbiological Assay for Pharmaceutical Analysis

6WHS&DOFXODWHUHJUHVVLRQ=ZHLJKLQJVDV ,W LV FRQYHQLHQW WR H[SUHVV WKLV OHQJWK\ FDOFXODWLRQ DV UHJUHVVLRQ = ZHLJKLQJV $²%²& ZKHUH $ > 6$+²6$/ @> 6%+²6%/ @> 8$+²8$/ @> 8%+² 8%/ @ % UHJUHVVLRQVTXDUHVIRUVWDQGDUG ^> 6$+6%+ ² 6$/6%/ @` & UHJUHVVLRQVTXDUHVIRUXQNQRZQ ^> 8$+8%+ ² 8$/8%/ @` VRWKDW

$ > ² @> ² @`> ² @ > ² @`  % ^>  ²  @`  & ^>  ²  @` 

DQGUHJUHVVLRQ=ZHLJKLQJV ²²  TABLE 9.13A Summary of the Analysis of Variance for Example 9.4a, a Two-Dose Level Assay Comparing One Unknown With the Reference Standard Using a Large Plate and an 8 = 8 Latin Square Design, with Duplicate Weighings of Each of the Two Preparations Sum of Mean d.f. Squares Squares

Variance Ratio

Limiting Value

At Arbitrary Probability Level, P

Calculated Probability

3UHSDUDWLRQV 5HJUHVVLRQ 3DUDOOHOLVP >GHYLDWLRQVIURP@ :HLJKLQJVZLWKLQ SUHSDUDWLRQV 5HJUHVVLRQ= ZHLJKLQJV

  

  

 ! 

  

  

Source of Variance

     





























6XEWRWDO





7UHDWPHQWV 5RZV &ROXPQV (UURUE\GLIIHUHQFH

   

   

  

  

 

 

 

7RWDO





1RWH/LPLWLQJYDOXHVLQFROXPQUHIHUWRWKHFRUUHVSRQGLQJDUELWUDU\SUREDELOLW\OHYHORIFROXPQ

Parallel-Line Assays — Some Designs and Their Evaluation

139

Discussion of Assay Validity Based on the Analysis of Variance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ÀGHQFH OLPLWVIRUWKHSRWHQF\HVWLPDWHPD\EHFDOFXODWHG 6WHS  &DOFXODWH WKH WHUP 6[[ WKH VXP RI WKH VTXDUHV RI GHYLDWLRQV RI LQGLYLGXDOORJGRVHVIURPWKHPHDQORJGRVH7KHGRVHUDWLRLVVRWKH ORJGRVHLQWHUYDOLV7KHUHDUHKLJKDQGORZGRVHVVRWKH YDOXHLVREWDLQHGDV >   ² @  6WHS&DOFXODWHJWKHLQGH[RIVLJQLÀFDQFHRIWKHVORSHEXVLQJ(TXDWLRQ  DV J

 =       = 

7KHYDOXHRIJLVZHOOEHORZWKHOLPLWRIDQGVRWKHYDULDQFHRI0DQGFRQÀGHQFH OLPLWVPD\EHFDOFXODWHGE\WKHDSSUR[LPDWHPHWKRG 6WHS&DOFXODWHWKHYDULDQFHRI0E\(TXDWLRQ  DV 90 

 •     —



 ³  –    µ˜

       6WHS&DOFXODWHV0E\(TXDWLRQ  DV V0    

140

Microbiological Assay for Pharmaceutical Analysis

6WHS/RJSHUFHQWFRQÀGHQFHOLPLWVDUH “= WR FRUUHVSRQGLQJWRFRQÀGHQFHOLPLWVRIWR

EXAMPLE 9.4B A MORE CRITICAL EXAMINATION DUPLICATE WEIGHINGS

OF AN

ASSAY

WITH

7KHUDZGDWDRI([DPSOHDUHH[DPLQHGKHUHLQ([DPSOHELQPRUHGHWDLOWR JDLQ DQ LQVLJKW LQWR WKH PHDQLQJV RI WKH FRPSRQHQWV RI YDULDWLRQ DWWULEXWHG WR GLIIHUHQFHV LQ WKH WZR ZHLJKLQJV RI VWDQGDUG DQG XQNQRZQ$ VLPSOH FRPSDULVRQ RI VWDQGDUG % ZLWK VWDQGDUG $ DQG VLPLODUO\ D FRPSDULVRQ RI XQNQRZQ % ZLWK XQNQRZQ$ZLOOJLYHÀJXUHVWKDWDUHLPPHGLDWHO\PHDQLQJIXOWRWKHDQDO\VW8VLQJ WKHYDOXHRIEREWDLQHGIURPDFRQVLGHUDWLRQRIDOOUHVSRQVHV  FDOFXODWH WKHSRWHQF\RIVWDQGDUG%LQWHUPVRIVWDQGDUG$ )    <      ² 0  ) E  ²   ² 5  DQWLORJ ²    6LPLODUO\FDOFXODWHWKHSRWHQF\RIXQNQRZQ%LQWHUPVRIXQNQRZQ$ )    <       0  ) E      5  DQWLORJ    ,Q URXQG ÀJXUHV WKH GLVFUHSDQFLHV EHWZHHQ ZHLJKLQJV % DQG ZHLJKLQJV $ DUH ² LQ WKH FDVH RI WKH VWDQGDUGV DQG  LQ WKH FDVH RI WKH XQNQRZQV 7KLV LV FOHDUO\ QRW JRRG HQRXJK LQ DQ DVVD\ LQWHQGHG WR EH RI TXLWH KLJK DFFXUDF\ DQG SUHFLVLRQ = ²² = @ =   6WHS&DOFXODWH)WKHPHDQGLIIHUHQFHLQ XQFRUUHFWHG UHVSRQVHVEHWZHHQ WKHXQNQRZQDQGWKHUHIHUHQFHIRUWKHÀQDOJURXSRIWKUHHSODWHV

163

Parallel-Line Assays — Some Designs and Their Evaluation

0HDQ=RQH'LDPHWHUPP





















'RVH,8PORQORJDULWKPLFVFDOH REVHUYHGYDOXHVVWDQGDUGVDQGUHIHUHQFHSRLQW FDOFXODWHGLGHDOYDOXHVIRUORZDQGKLJKGRVHV

REVHUYHGYDOXHXQNQRZQ

FIGURE 9.6 $ JUDSKLFDO UHSUHVHQWDWLRQ RI WKH GDWD RI H[DPSOH  ,W LV EDVHG RQ WKH FRUUHFWHGPHDQ]RQHVL]HVRI7DEOH7KHVWUDLJKWOLQHLVGUDZQWRMRLQWKHYDOXHVRI / DQG+WKDWZHUHFDOFXODWHGXVLQJ(TXDWLRQ  DQG(TXDWLRQ  UHVSHFWLYHO\

)  ²  ² 6WHS&DOFXODWHEWKHPHDQGLIIHUHQFHLQUHVSRQVHIRUDWHQIROGLQFUHDVHLQ GRVH E (, ORJ  6WHS&DOFXODWHWKHYDOXHRI0WKHORJDULWKPRIWKHUDWLRRIWKHSRWHQF\RI XQNQRZQWRWKDWRIWKHVWDQGDUG 0 )E ² ² 6WHS  &DOFXODWH SRWHQF\ HVWLPDWH RI WKH XQNQRZQ WHVW VROXWLRQ UHODWLYH WR WKDWRIWKHUHIHUHQFHWHVWVROXWLRQ DQWLORJ0  &RPSDUHWKLVZLWKREWDLQHGJUDSKLFDOO\ 6WHS&DOFXODWHSRWHQF\HVWLPDWHRIWKHVDPSOH$FWXDOSRWHQF\HVWLPDWHRI WKHXQNQRZQWHVWVROXWLRQLV == ,8PO

164

Microbiological Assay for Pharmaceutical Analysis

7KHFRQFHQWUDWLRQRIWKHWHVWVROXWLRQLV+JPO RUPJPO VRWKDW HVWLPDWHGSRWHQF\LV  ,8PJ 7KHUHIRUH D YLDO KDYLQJ DQ DYHUDJH ZHLJKW RI FRQWHQWV RI  J LV HVWLPDWHG WR FRQWDLQ  =   PJRINDQDP\FLQEDVH  Statistical Evaluation 6WHS  )URP WKH FRUUHFWHG GDWD RI7DEOH  FDOFXODWH WKH WRWDO GHYLDWLRQ VTXDUHVDV







    7    <   

    <      

PHDQFRUUHFWLRQ 0&



       

6WHS)URPWKHWUHDWPHQWWRWDOVFDOFXODWH

 





               < 0&

     <       6WHS)URPWKHSUHSDUDWLRQWRWDOVFDOFXODWH

             < 0& 



       <      6WHS8VLQJRUWKRJRQDOSRO\QRPLDOFRHIÀFLHQWVFDOFXODWHVTXDUHVIRUUHJUHV VLRQDQGGHYLDWLRQVIURPUHJUHVVLRQVTXDUHVDVVKRZQLQ7DEOH 6WHS  ,QVHUW WKH NQRZQ GHYLDWLRQ VTXDUHV LQ 7DEOH  WKH VXPPDU\ RI DQDO\VLVRIYDULDQFHDQGFDOFXODWHWKHUHVLGXDOHUURUVTXDUHVE\GLIIHUHQFH Discussion of Assay Validity Based on the Analysis of Variance )LUVW D FRPPHQW RQ WKH QXPEHU RI GHJUHHV RI IUHHGRP LV DSSURSULDWH )RU WKH FDOFXODWLRQV XVLQJ RUWKRJRQDO SRO\QRPLDO FRHIÀFLHQWV WKH YDOXH RI WKH UHIHUHQFH

165

Parallel-Line Assays — Some Designs and Their Evaluation

TABLE 9.21 Factorial Coefficients for a Five-Dose Level Standard Curve Applied to the Data of Example 9.10

E T U V

S1

S2

S3

S4

S5

ei

²  ² 

² ²  ²

 ²  

 ² ² ²

   

   









7UHDWPHQWWRWDOVA 

Ti

Ti2/(9 = ei)

  ²    ²  

TABLE 9.22 Summary of Analysis of Variance for Example 9.6, an Assay Using Small Plates and the USP Five-Dose Level Standard Curve Procedure

Source of Variance d.f.

Sum of Squares

Mean Squares

Variance Limiting Ratio Value

3UHSDUDWLRQV 5HJUHVVLRQ 4XDGUDWLFFXUYDWXUH &XELFFXUYDWXUH 4XDUWLFFXUYDWXUH

    

    

    

    

6XEWRWDO





7UHDWPHQWV (UURUE\GLIIHUHQFH

 

 

 



7RWDO





 !   

At Arbitrary Probability Level, P

Calculated Probability

    

    

1RWH/LPLWLQJYDOXHVLQFROXPQUHIHUWRWKHFRUUHVSRQGLQJDUELWUDU\SUREDELOLW\OHYHORIFROXPQ 1RWH$GMDFHQW GRVH OHYHOV RI VWDQGDUG ZHUH LQ WKH UDWLR  7KHUH ZDV D VLQJOH OHYHO RI WKH XQNQRZQ SUHSDUDWLRQ

SRLQWZDVXVHGHIIHFWLYHO\QLQHWLPHVVRWKDWWKHQXPEHURIUHVSRQVHVXVHGLQWKH FDOFXODWLRQZDVZKLFKZRXOGQRUPDOO\OHDGWRDWRWDORIGHJUHHVRIIUHHGRP +RZHYHUWKHUHZHUHQRWQLQHLQGHSHQGHQWUHIHUHQFHSRLQWVDQGVRHIIHFWLYHO\WKHUH ZHUHRQO\LQGHSHQGHQWUHVSRQVHVOHDGLQJWRDWRWDORIGHJUHHVRIIUHHGRP ,QWKLVDVVD\WKHSKDUPDFRSRHLDOUHTXLUHPHQWVFRQFHUQLQJYDULDQFHUDWLRVDSSO\ WRUHVSRQVHVWRWKHÀYHVWDQGDUGWUHDWPHQWVRQO\WKDWLVWRUHJUHVVLRQDQGGHYLDWLRQV IURPOLQHDULW\7KHODWWHULVEURNHQGRZQLQWRLWVFRPSRQHQWSDUWVTXDGUDWLFFXELF DQGTXDUWLFFXUYDWXUH9DULDQFHUDWLRVIRUWKHWKUHHGHYLDWLRQVIURPOLQHDUUHJUHVVLRQ ZHUHDOOZHOOZLWKLQWKHOLPLWDQGQRWVWDWLVWLFDOO\VLJQLÀFDQW+RZHYHUWKHUHOLDELOLW\

166

Microbiological Assay for Pharmaceutical Analysis

RIWKHVHÀJXUHVLVTXHVWLRQDEOH7KHSUHOLPLQDU\LQVSHFWLRQRIGDWDVKRZHGWKDWWKH UDQJHVRIUHVSRQVHVWRDGMDFHQWWUHDWPHQWOHYHOVRYHUODSSHGLQWZRFDVHV7KLVRYHUODS VXJJHVWHG WKHUHIRUH WKDW WKH ÀJXUHV IRU FXELF DQG TXDUWLF FXUYDWXUH PD\ ZHOO EH GXHWRUDQGRPHUURU$OWKRXJKTXDGUDWLFFXUYDWXUHPLJKWEHH[SHFWHGRQWKHRUHWLFDO JURXQGVWKLVDVVD\ZLWKDQRYHUDOOVKRUWGRVHUDQJHPD\EHLQVXIÀFLHQWO\VHQVLWLYH WRGHWHFWWUXHFXUYDWXUH:KDWLVVHHQPD\EHGXHWRUDQGRPHUURU ,WPD\EHDSSURSULDWHWRFDOFXODWHDSRROHGHUURUWHUPFRPSULVLQJWKHUHVLGXDO HUURUSOXVDOOGHYLDWLRQVIURPOLQHDUUHJUHVVLRQ7KLVSRVVLELOLW\ZLOOEHH[SORUHGLQ WKH´$OWHUQDWLYH&DOFXODWLRQµ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²SHUFHQWPD\EHH[SHFWHG 7KLV WRSLFLVGLVFXVVHGLQ&KDSWHU  7KH DVVHVVPHQW RI WKH DQDO\VLV RI YDULDQFH LV VDWLVIDFWRU\ DQG VR FRQÀGHQFH OLPLWVIRUWKHSRWHQF\HVWLPDWHPD\EHFDOFXODWHG&DOFXODWHWKHWHUP6[[WKHVXP RI WKH VTXDUHV RI GHYLDWLRQV RI LQGLYLGXDO ORJ GRVHV IURP WKH PHDQ ORJ GRVH7KH GRVHUDWLRLVVRWKHORJGRVHLQWHUYDOLV7KHGHYLDWLRQVIURPWKHPHDQ ORJGRVHDUHRQHORJGRVHLQWHUYDO GRVHOHYHOVDQG DQGWZRORJGRVHLQWHUYDOV GRVHOHYHOVDQG WKHUHSOLFDWLRQLVVRWKDW6[[LVREWDLQHGDV









  =    EV=6[V\@>EX=6[X\@ 6TXDUHVIRUGHYLDWLRQVIURPUHJUHVVLRQDUHREWDLQHGDVWKHGLIIHUHQFH SUHSDUDWLRQVTXDUHV²UHJUHVVLRQVTXDUHV 6TXDUHVIRUUHVLGXDOHUURUDUHREWDLQHGDVWKHGLIIHUHQFH WRWDOVTXDUHV²SUHSDUDWLRQVTXDUHV



174

Microbiological Assay for Pharmaceutical Analysis

6WHS&DOFXODWHJWKHLQGH[RIVLJQLÀFDQFHRIWKHVORSHXVLQJWKHH[SUHVVLRQ J



V  = W  = 6[X [X

EV  6[ V [ V  6[X [X <  6[ V [X







6WHS:KHQJLVOHVVWKDQ DVLWLQYDULDEO\LVLQDQ\DVVD\WKDWLVRIDQ\ YDOXH FDOFXODWHWKHYDULDQFHRIWKHSRWHQF\UDWLR9 5 XVLQJWKHVLPSOLÀHG H[SUHVVLRQ • V  — • 6[ [  56[ V [X 5  6[X [X — µ 9  5  ³  µ = ³ V V  – EV ˜ ³–  6[ V [ V  6[X [X <  6[ V [X µ˜



6WHS2EWDLQWKHVWDQGDUGHUURURIWKHSRWHQF\UDWLRV5DV V5 >9 5 @



6WHS3URFHHGWRWKHFDOFXODWLRQRIFRQÀGHQFHOLPLWVDV 5“W=V5



EVALUATION OF A TWO-DOSE LEVEL ASSAY USING THE BLISS PROCEDURE $ QLDFLQ DVVD\ FDUULHG RXW LQ  ZLOO EH XVHG WR LOOXVWUDWH WKLV FDOFXODWLRQ 7KH UDZGDWDDUHSUHVHQWHGLQ7DEOH (;$03/( 7KHDVVD\RIQLDFLQXVLQJDÀYHSRLQWFRPPRQ]HURDVVD\GHVLJQ 7HVWRUJDQLVP/DFWREDFLOOXVDUDELQRVXV1&,% 6WDQGDUGGRVHOHYHOVDQG+JPO 6DPSOHGRVHOHYHOVQRPLQDOO\DQG+JPO

$V PHQWLRQHG LQ WKH VHFWLRQ RQ SUHOLPLQDU\ HYDOXDWLRQ RIWHQ LQ VORSH UDWLR DVVD\VUHVSRQVHVWR]HURGRVHDUHQRWFROOLQHDUZLWKUHVSRQVHVWRGRVHVRIVWDQGDUG DQGRIXQNQRZQ&RPSDULVRQRIWKHVORSHVLQ7DEOHVKRZVWKDWVXFKLVWKHFDVH LQWKLVH[DPSOH7KHH[WHQWRIGHYLDWLRQIURPFROOLQHDULW\LVLOOXVWUDWHGYLVXDOO\LQ

175

Slope Ratio Assays — Some Designs and Their Evaluation

TABLE 10.1 The Raw Data from Example 10.1, a Turbidimetric Assay of Niacin Using a Five-Point Common-Zero Design Standard Doses A

Zero

Low

High

Unknown Low

High

   

   

   

   

   

7UHDWPHQWWRWDOVA











7UHDWPHQWPHDQVA











6ORSHVEDVHGRQPHDQUHVSRQVHV VWDQGDUGORZ²]HUR



VWDQGDUGKLJK²VWDQGDUGORZ



XQNQRZQORZ²]HUR



XQNQRZQKLJK²XQNQRZQORZ



1RWH5HFRUGHGREVHUYDWLRQVDUH=RSWLFDODEVRUEDQFHDWQP

)LJXUH  DQG )LJXUH  ,Q )LJXUH  OLQHV RI EHVW ÀW DUH SORWWHG EDVHG RQ DOO PHDQ UHVSRQVHV LQ )LJXUH  OLQHV RI EHVW ÀW DUH SORWWHG H[FOXGLQJ PHDQ UHVSRQVHWR]HURGRVH,WDSSHDUHGIURPWKHJUDSKVWKDWGHYLDWLRQZDVQRWVHULRXV ,QFDVHVZKHUHWKHPHDQ]HURGRVHUHVSRQVHGHYLDWHVVLJQLÀFDQWO\IURPFROOLQHDULW\ LWLVSHUPLVVLEOHWRRPLWLWIURPWKHFDOFXODWLRQ ,WZDVVKRZQLQWKHVWDWLVWLFDOHYDOXDWLRQWKDWIROORZVWKDWWKHGHYLDWLRQZDVQRW VLJQLÀFDQWDQGVRUHWHQWLRQRI]HURGRVHUHVSRQVHVZDVMXVWLÀHG 6WHS8VLQJFRGHGGRVHVDQGIRUORZDQGKLJKGRVHOHYHOVUHVSHF WLYHO\ FDOFXODWH WKH EDVLF IXQFWLRQV RI GRVH E\ XVLQJ (TXDWLRQ  DQG (TXDWLRQDV 6[ V      6[X     

176

5HVSRQVH[2SWLFDO$EVRUEDQFHDWQP

Microbiological Assay for Pharmaceutical Analysis          





'RVH1LDFLQ+JP( UHIHUHQFHVWDQGDUG

XQNQRZQ

]HURGRVH

5HVSRQVH[2SWLFDO$EVRUEDQFHDWQP

FIGURE 10.1 $JUDSKLFDOUHSUHVHQWDWLRQRIDOOPHDQUHVSRQVHVLQ([DPSOH5HVSRQVHV WR]HURGRVHGHYLDWHVOLJKWO\IURPEHLQJFROOLQHDUZLWKWKRVHWRGRVHOHYHOVDQG7KHVOLJKW FXUYDWXUH RI WKH UHVSRQVH OLQHV LV MXVW GHWHFWDEOH RQ FDUHIXO LQVSHFWLRQ +RZHYHU FRPSDUH ZLWK)LJXUH

         





'RVH1LDFLQ+JP( UHIHUHQFHVWDQGDUG

XQNQRZQ

]HURGRVH

FIGURE 10.2 $ JUDSKLFDO UHSUHVHQWDWLRQ RI WKH PHDQ UHVSRQVHV WR GRVH OHYHOV  DQG  RI UHIHUHQFHVWDQGDUGDQGXQNQRZQLQ([DPSOH7KHWZRUHVSRQVHOLQHVFRLQFLGHZLWKWKH \ D[LV ]HUR GRVH  DW D YDOXH RI  ZKHUHDV WKH REVHUYHG PHDQ UHVSRQVH WR WKH ]HURGRVH FRQWUROVZDV7KLVGRHVQRWDSSHDUWREHDVHULRXVGLVFUHSDQF\EXWVHUYHVWRLOOXVWUDWHWKH SULQFLSOHVRQZKLFKLWPLJKWEHDSSURSULDWHWRRPLWIURPWKHFDOFXODWLRQVWKHDFWXDOUHVSRQVHV WR]HURGRVH

177

Slope Ratio Assays — Some Designs and Their Evaluation

6WHS  &DOFXODWH WKH YDOXHV RI WKH WKUHH IXQFWLRQV RI GRVH XVLQJ (TXDWLRQ WR(TXDWLRQ









 6[ V [ V  S      <       6[X [X  T      <       6[ V [X  U   <  =